VTRLY OTC
Vitrolife AB (publ)
1W: +0.0%
1M: +0.0%
3M: -13.9%
YTD: -36.9%
1Y: -36.7%
3Y: -19.4%
5Y: -62.2%
$9.50
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$3.4B
-4.7% ▼
5Y CAGR: +22.5%
Gross Profit
$2.0B
-6.6% ▼
5Y CAGR: +21.1%
Operating Income
$579M
-26.0% ▼
5Y CAGR: +9.4%
Net Income
-$4.7B
-1018.4% ▼
EPS (Diluted)
$-34.79
-1020.4% ▼
EBITDA
$980M
-15.4% ▼
5Y CAGR: +17.5%
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $1.7B | $3.2B | $3.5B | $3.6B | $3.4B |
| YoY Growth | +34.9% | +92.4% | +8.6% | +2.8% | -4.7% |
| Cost of Revenue | $635M | $1.5B | $1.5B | $1.5B | $1.4B |
| Gross Profit | $1.0B | $1.8B | $2.0B | $2.1B | $2.0B |
| Gross Margin | 62.2% | 55.0% | 56.3% | 59.3% | 58.1% |
| R&D Expenses | $114M | $143M | $228M | $117M | $104M |
| SG&A Expenses | $504M | $1.0B | $1.1B | $1.2B | $1.3B |
| Operating Expenses | $620M | $1.1B | $5.6B | $1.4B | $6.8B |
| Operating Income | $435M | $654M | -$3.6B | $783M | $579M |
| Operating Margin | 25.9% | 20.2% | -102.2% | 21.7% | 16.8% |
| Interest Expense | $10M | $44M | $94M | $98M | $48M |
| Income Before Tax | $460M | $537M | -$3.7B | $674M | -$4.6B |
| Tax Expense | $116M | $143M | $139M | $160M | $119M |
| Net Income | $341M | $394M | -$3.9B | $513M | -$4.7B |
| Net Margin | 20.3% | 12.2% | -109.7% | 14.2% | -137.0% |
| EPS (Diluted) | $2.97 | $2.91 | $-28.44 | $3.78 | $-34.79 |
| EBITDA | $579M | $977M | -$3.2B | $1.2B | $980M |
| Shares Outstanding | 115M | 135M | 135M | 136M | 135M |